SCHEMBL4811045

SCHEMBL4811045

O=C(O)c1nc2cc(O)ccc2[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 2/20 0.54
SMAD3 P84022 1/20 0.50
RHEB Q15382 1/20 0.46
FLT3 P36888 4/20 0.43
PDGFRB P09619 2/20 0.43
ABL1 P00519 1/20 0.43
KIT P10721 1/20 0.43
BCR P11274 1/20 0.43
PLAU P00749 1/20 0.40
MAPT P10636 2/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
FAAH O00519 1/20 0.39
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
PDGFRA P16234 1/20 0.38
AURKA O14965 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27989554 0.87 FLT3 (0.49) PIN1SMAD3FLT3PDGFRBABL1
SCHEMBL4806542 0.86 PIN1 (0.68) PIN1SMAD3RHEBPLAUKDM4E
SCHEMBL2243699 0.81 PIN1 (0.53) PIN1RHEBFLT3ALDH1A1KDM4E
SCHEMBL28429591 0.81 PIN1 (0.53) PIN1SMAD3RHEBPDGFRBABL1
SCHEMBL2214853 0.81 PIN1 (0.76) PIN1RHEBMAPTALDH1A1KDM4E
SCHEMBL4399173 0.81 PIN1 (0.53) PIN1RHEBMAPTALDH1A1KDM4E
SCHEMBL523253 0.81 RHEB (0.54) PIN1RHEBMAPTALDH1A1KDM4E
SCHEMBL482085 0.81 PIN1 (0.53) PIN1RHEBMAPTKDM4E
SCHEMBL31024214 0.81 PIN1 (0.53) PIN1RHEBPDGFRBABL1MAPT
SCHEMBL9737654 0.79 DAGLA (0.43) PIN1SMAD3FLT3PDGFRBABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 US disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 WO disclosed
CN-111426673-A Gold and silver hybrid nano-particles and preparation method and application thereof 南京工业大学 2020-07-17 CN disclosed
US-7378431-B2 Amide derivatives as NMDA receptor antagonists RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2008-05-27 US disclosed
US-7375116-B2 Amide derivatives as NMDA receptor antagonists RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2008-05-20 US disclosed
US-7365083-B2 Amide derivatives as NMDA receptor antagonists RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2008-04-29 US disclosed
US-7361670-B2 Amide derivatives as NMDA receptor antagonists RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2008-04-22 US disclosed
US-20050159451-A1 Amide derivatives as NMDA receptor antagonists HORVATH CSILLA (HU) 2005-07-21 US disclosed
US-6919355-B2 Amide derivatives as NMDA receptor antagonists RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2005-07-19 US disclosed
US-20050113359-A1 Amide derivatives as NMDA receptor antagonists HORVATH CSILLA (HU) 2005-05-26 US disclosed
US-20050113361-A1 Amide derivatives as NMDA receptor antagonists HORVATH CSILLA (HU) 2005-05-26 US disclosed
US-20050113360-A1 Amide derivatives as NMDA receptor antagonists HORVATH CSILLA (HU) 2005-05-26 US disclosed
US-20030199552-A1 Amide derivatives as NMDA receptor antagonists RICHTER GEDEON VEGYESZETI GYAR RT. 2003-10-23 US disclosed
WO-1991019475-A2 QUINOLINYL-BENZOHETEROBICYCLIC DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D¿4? RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1991-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113361-A1 Amide derivatives as NMDA receptor antagonists GRIN1, GRIN3A, GRIN2B PIN1 3851/4885SMAD3 1484/4885RHEB 4039/4885
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS MLLT3, YEATS2, MLLT1 PIN1 4653/4885SMAD3 2190/4885RHEB 4033/4885
US-20050113360-A1 Amide derivatives as NMDA receptor antagonists GRIN1, GRIN3A, GRIN2B PIN1 3023/4885SMAD3 1171/4885RHEB 4291/4885
US-20050159451-A1 Amide derivatives as NMDA receptor antagonists GRIN1, GRIN3A, GRIN2B PIN1 3190/4885SMAD3 958/4885RHEB 4091/4885
US-20050113359-A1 Amide derivatives as NMDA receptor antagonists GRIN1, GRIN3A, GRIN2B PIN1 3970/4885SMAD3 1413/4885RHEB 3978/4885
US-20030199552-A1 Amide derivatives as NMDA receptor antagonists GRIN1, GRIN3A, GRIN2C PIN1 4306/4885SMAD3 2038/4885RHEB 4200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.